Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-01
DOI
10.1007/s10072-021-05216-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Risk for Fingolimod, Natalizumab, and Rituximab in MS Patients
- (2020) Peter Alping et al. ANNALS OF NEUROLOGY
- Advances in oral immunomodulating therapies in relapsing multiple sclerosis
- (2020) Tobias Derfuss et al. LANCET NEUROLOGY
- Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
- (2020) Esther Melamed et al. Frontiers in Immunology
- Established and Emerging Immunological Complications of Biological Therapeutics in Multiple Sclerosis
- (2019) Babak Soleimani et al. DRUG SAFETY
- Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort
- (2019) Emanuele D'Amico et al. Frontiers in Neurology
- Disease-modifying treatments for early and advanced multiple sclerosis
- (2018) Gavin Giovannoni CURRENT OPINION IN NEUROLOGY
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) X. Montalban et al. EUROPEAN JOURNAL OF NEUROLOGY
- Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
- (2018) Alexander Rae-Grant et al. NEUROLOGY
- Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs
- (2018) Christine Lebrun et al. CNS DRUGS
- Estimates of cancer burden in Italy
- (2018) Silvia Rossi et al. TUMORI
- The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
- (2017) Gabriel Pardo et al. JOURNAL OF NEUROLOGY
- Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study
- (2017) Xavier Moisset et al. PLoS One
- Malignancies after mitoxantrone for multiple sclerosis
- (2016) Mathias Buttmann et al. NEUROLOGY
- The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study
- (2016) Emanuele D’Amico et al. PLoS One
- Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial
- (2014) Luca Massacesi et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Cancer and multiple sclerosis in the era of disease-modifying treatments
- (2011) Christine Lebrun et al. JOURNAL OF NEUROLOGY
- Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis
- (2008) Christine Lebrun et al. Multiple Sclerosis Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now